The largest database of trusted experimental protocols

7 protocols using cd3 clone 145 2c11

1

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To perform surface staining, 1 × 106 cells were placed in individual wells of a 96-well round bottom plate and incubated with the appropriate antibody cocktails for 15 min at 4°C on a slow rocker. After the staining, cells were fixed in a solution of 2% ultrapure formaldehyde (Polysciences, Inc., Warrington, PA, USA) in FACS buffer for 20 min on ice, washed twice, and analyzed the following day on the Canto II (BD Biosciences) or FACSCalibur (BD Biosciences). Intracellular staining was performed using Cytofix/Cytoperm Fixation/Permeabilization Solution Kit with BD GolgiStop (BD biosciences) according to the manufacturer’s instruction. Flow cytometry acquisition was performed on an LSRIISorp. Data were analyzed using FACS Express or FlowJo software (Tree Star, Inc., Ashland, OR, USA). Antibodies against CD45 (clone 30-F11, BD Pharmingen), CD3 (clone 145-2C11, BD Pharmingen), CD4 (clone GK1.5, BD Pharmingen), CD8 (clone 5H10, Biolegend), T-bet (clone eBio4B10, eBioscience), IL-17A (clone ebio17B7, eBioscience), IL-4 (clone B11B, Biolegend), IFNγ (clone XMG 1.2, eBioscience), IL-22 (clone A3.6M, eBioscience and clone poly5164, Biolegend), TGF-β (clone 11A5, Biolegend), IL-17F (clone ebio18F10, eBioscience), NKP46 (clone 29A 1.4, Biolegend), c-Kit (clone 2B8, Biolegend), Sca-1 (clone D7, BD Pharmingen), and CD127 (clone A7R34, eBioscience) were used.
+ Open protocol
+ Expand
2

Multiparameter Flow Cytometry of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies used for flow cytometry included B220 (RA3-6B2, Biolegend), CD3 (clone 145-2C11, BD Biosciences), CD4 (RM4-5, Biolegend), CD8 (53-6.7, Biolegend), CD11b (M1/70, eBioscience), CD11c (N418, eBioscience), CD38 (90, eBioscience), CD44 (IM7, eBioscience), F4/80 (BM8, eBioscience), GL7 (GL7, BD Biosciences), Gr-1 (RB6, eBioscience), IgM (eB121-15F9, eBioscience), IL-17A (TC11-18H10, BD Biosciences), IL-17F (18F10, eBioscience), and IL-17RA (PAJ-17R, eBioscience).
+ Open protocol
+ Expand
3

Evaluating Immune Cell Populations in Spleen and Heart

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleen and heart fragments were collected to evaluate IFN-γ-producing CD4+ T cells, IL-10-producing Tregs, and IL-10-producing Tr1 cells. To isolate mononuclear cells from cardiac tissues, the hearts were removed at 15 d.p.i. washed (to remove blood clots), minced with scissors into small fragments, extensively washed, and subjected to enzymatic digestion with 500 mg/mL of Liberase solution (Roche Applied Science, Indianapolis, IN, USA) for 1 h at 37°C. The tissues were washed with RPMI 10% FCS and total cells that passed through the cell strainer were subsequently counted. Two million leukocytes from heart tissue or from spleen were stimulated in vitro with PMA/Ionomycin/Golgi Stop for 6 h. The leukocytes were stained with specific antibodies for Cd11b (clone MI/70 BD), I-A/E (clone 269 BD), CD3 (clone 145-2C11), CD4 (clone RM4-5 BD), Foxp3 (clone MF 23 BD), IFN-γ (clone XMG 1.2 BD), IL-10 (clone JESS-16E3 BD), and IL-27p28 (clone MM27-7b1 Biolegend), and evaluated by flow cytometry.
+ Open protocol
+ Expand
4

Multicolor Flow Cytometry of Leukocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Leukocytes from spleen, lung, and BAL were analyzed by flow cytometry for cell surface markers. Cells were stained with monoclonal antibodies (mAbs) reactive against different hematopoietic cell surface molecules, and conjugated with either fluorescein isothiocyanate, phycoerythrin or allophycocyanin: NK1.1 (clone PK136), CD3 (clone 145-2C11), DX5, CD4 (clone RM4–5), CD8 (clone 53–6.7), B220/CD45R (clone RA3-6B2), and CD11b (clone M1/70) (BD Pharmingen, San Diego, CA) and incubated on ice for 30 minutes. Cells were washed and resuspended in SM containing propidium iodide to differentiate between live and dead cells. Live cells were gated and the percentages of NK, NKT, CD3, CD4 and CD8 -positive T cells were enumerated. NK cells were characterized as NK1.1+ and CD3. Various subsets of NK cells were characterized using additional markers such as B220 and CD11b (Mac-1). NKT cells were characterized phenotypically as NK1.1+CD3+ cells. Fluorescence was evaluated using a FACS Calibur analyzer or Accuri C6 and data was processed using CellQuest and FlowJo Software. Lymphocyte gates were designated on the basis of forward and side scatter analysis.
+ Open protocol
+ Expand
5

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluorescently labeled monoclonal antibodies against the following mouse antigens were used: CD3 (clone 145–2 C11, BD Biosciences), CD4 (clone RM4-5, BioLegend), CD8a (clone 53–6.7, BioLegend), CD8b (clone YTS156.7.7, BioLegend), CD11a (clone M17/4, eBioscience), CD127 (clone A7R34, Thermo Fisher), KLRG-1 (clone 2F1, Thermo Fisher), CD44 (clone IM7, BioLegend), CD49a (clone Ha31/8, BD Biosciences), CD62L (clone MEL-14, BioLegend), CD69 (clone H1.2F3, BD Biosciences), CD38 (clone 90, Thermo Fisher) and CD103 (clone 2E7, Thermo Fisher). Cells were stained according to our previously published protocol.33 (link) 7-AAD (A1310, Invitrogen) staining was used to exclude dead cells. E7-specific CD8+ T cells were quantified using MHC class I tetramers for the RAHYNIVTF epitope. Flow cytometric acquisition was performed on a BD Fortessa flow cytometer (BD Biosciences).
+ Open protocol
+ Expand
6

T Cell Activation via CD3/CD28 Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells were stimulated with immobilized CD3×CD28 mAbs as previously described [25 (link)]. Briefly, SuperAvidin™-coated polystyrene microspheres (Bangs laboratories, Inc., Ø ~ 10 μm, binding capacity: 0,02-0,04 μg biotin/mg) were coated with biotinylated CD3 (clone UCHT1) and CD28 (clone CD28.2) mAbs (10 μg/ml each, BioLegend) for 30 min at 37°C in PBS Dulbecco (Biochrom AG). Antibody-coated microspheres were washed three times, resuspended in PBS at 108 beads/ml and incubated with T cells in a 1 bead per cell ratio. Microspheres coated with 20 μg/ml of biotinylated mouse IgG1κ (eBioscience) were used as a control.
Stimulations in the presence of 100 U/ml superoxide dismutase from bovine erythrocytes, 1000 U/ml catalase from Corynebacterium glutamicum and 100 μM L-ascorbic acid (all from Sigma-Aldrich) were performed by pre-incubating T cells for 30 min with the compounds before stimulation.
Mouse T cells were stimulated with CD3 (clone 145-2C11) and CD28 (clone 37.51) mAbs (10 μg/ml each, both from BD Pharmingen) immobilized on microspheres as described above. Microspheres coated with biotinylated hamster IgG1κ and IgG2λ1 (10 μg/ml each, both from BD Pharmingen) were used as a control.
+ Open protocol
+ Expand
7

Multicolor Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies against B220 (clone RA3-6B2), CD3 (clone 145-2C11), CD4 (clone GK1.5), CD8 (clone 53-6.7), CD11b (clone M1/70), CD45.1 (clone A20), CD45.2 (clone 30-F11), H-2K d (clone SF1-1.1), H-2K b (clone 25-D1.16), and IA/IE (clone M5/114) labeled with various fluorescent dyes, their appropriate isotype controls, and 7aminoactinomycin D (7-AAD) were purchased from BD Biosciences (Franklin Lakes, NJ, USA). Cells were analyzed using a BD fluorescence-activated cell sorting (FACS) Canto II Flow Cytometer and BD FACS Diva software (BD Biosciences). Cells positive for 7-AAD staining were excluded from the analysis as nonviable cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!